KG Legal KIELTYKA GLADKOWSKI Shortlisted for The Legal 500 Central and Eastern Europe Awards 2026
Publication date: June 1, 2026
We are proud to announce that KG Legal Kieltyka Gladkowski has been shortlisted for the prestigious Central and Eastern Europe Awards 2026, organised by The Legal 500, in the category Healthcare & Life Sciences Firm of the Year. This distinction places our firm among the leading legal practices recognised for excellence in the healthcare, pharmaceutical, medical devices, biotechnology, and life sciences sectors across the region. Being shortlisted by The Legal 500 is considered one of the most significant recognitions in the legal market, reflecting not only legal expertise but also market reputation, client feedback, innovation, and the impact of a firm’s work.
https://www.legal500.com/events/central-eastern-europe-awards-2026
The Legal 500 is one of the world’s most respected and influential legal directories, conducting independent research into law firms and lawyers in more than 150 jurisdictions. Its rankings and awards are based on an extensive evaluation process that includes submissions from law firms, interviews with legal practitioners, analysis of representative matters, and, importantly, direct feedback from clients and market participants. The Central and Eastern Europe Awards recognise outstanding achievements across the CEE region and are founded on the same rigorous research methodology that underpins The Legal 500’s annual rankings. Winners and shortlisted firms are selected by the editorial team responsible for Legal 500’s coverage of Central and Eastern Europe, ensuring a highly competitive and independent assessment process.
The category Healthcare & Life Sciences Firm of the Year is dedicated to law firms demonstrating exceptional performance in advising clients operating within highly regulated healthcare and life sciences industries. The category encompasses legal work involving pharmaceuticals, biotechnology, medical devices, healthcare providers, clinical trials, regulatory compliance, market access, reimbursement, product liability, healthcare transactions, data protection in medical environments, and innovative health technologies. The award recognises firms that combine sector-specific expertise with a deep understanding of the evolving regulatory and commercial challenges facing healthcare and life sciences businesses. Legal 500’s own healthcare rankings highlight the breadth and complexity of matters considered within this practice area, ranging from pharmaceutical regulation and medical devices to compliance, clinical research, financing, and strategic transactions.
Being shortlisted means that KG Legal Kieltyka Gladkowski has been selected as one of a very limited number of firms considered finalists for this award following Legal 500’s extensive regional research. The distinction is particularly meaningful because the award is not granted within a local ranking exercise alone; it forms part of a regional competition covering Central and Eastern Europe, where leading firms from numerous jurisdictions compete for recognition. The shortlist therefore represents an acknowledgement that our healthcare and life sciences practice stands among the most highly regarded and competitive teams in the region. Previous editions of the awards have featured only a select group of nominated firms in each category, underlining the exclusivity of the recognition.
For KG Legal Kieltyka Gladkowski, this nomination is an important confirmation of our long-standing commitment to supporting healthcare, pharmaceutical, biotechnology, and medical technology clients with sophisticated legal and regulatory advice. It reflects the trust placed in us by our clients, the quality of our work, and our contribution to the development of one of the most dynamic and strategically important sectors of the economy. Being shortlisted for Healthcare & Life Sciences Firm of the Year at the Central and Eastern Europe Awards 2026 is therefore not only a significant professional achievement but also a recognition of our firm’s position within the broader Central and Eastern European legal market.
